{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:49:54Z","timestamp":1789951794855,"version":"4.0.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T00:00:00Z","timestamp":1455148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/bjc.2016.20","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T04:25:02Z","timestamp":1455251102000},"page":"519-523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Chetomin, targeting HIF-1\u03b1\/p300 complex, exhibits antitumour activity in multiple myeloma"],"prefix":"10.1038","volume":"114","author":[{"given":"Elena","family":"Viziteu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Grandmougin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Seckinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Moreaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,11]]},"reference":[{"issue":"6","key":"BFbjc201620_CR1","first-page":"810","volume":"90","author":"K Asosingh","year":"2005","unstructured":"Asosingh K, de Raeve H, de Ridder M, Storme GA, Willems A, van Riet I, van Camp B, Vanderkerken K (2005) Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression. Haematologica 90 (6): 810\u2013817.","journal-title":"Haematologica"},{"issue":"7","key":"BFbjc201620_CR2","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.18632\/oncotarget.1736","volume":"5","author":"E Borsi","year":"2014","unstructured":"Borsi E, Perrone G, Terragna C, Martello M, Dico AF, Solaini G, Baracca A, Sgarbi G, Pasquinelli G, Valente S, Zamagni E, Tacchetti P, Martinelli G, Cavo M (2014) Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma. Oncotarget 5 (7): 1779\u20131792.","journal-title":"Oncotarget"},{"issue":"13","key":"BFbjc201620_CR3","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1182\/blood-2007-02-074617","volume":"110","author":"S Colla","year":"2007","unstructured":"Colla S, Tagliaferri S, Morandi F, Lunghi P, Donofrio G, Martorana D, Mancini C, Lazzaretti M, Mazzera L, Ravanetti L, Bonomini S, Ferrari L, Miranda C, Ladetto M, Neri TM, Neri A, Greco A, Mangoni M, Bonati A, Rizzoli V, Giuliani N (2007) The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis. Blood 110 (13): 4464\u20134475.","journal-title":"Blood"},{"issue":"1","key":"BFbjc201620_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3324\/haematol.2010.030296","volume":"96","author":"D Hose","year":"2011","unstructured":"Hose D, Reme T, Hielscher T, Moreaux J, Messner T, Seckinger A, Benner A, Shaughnessy JD Jr ., Barlogie B, Zhou Y, Hillengass J, Bertsch U, Neben K, Mohler T, Rossi JF, Jauch A, Klein B, Goldschmidt H (2011) Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma. Haematologica 96 (1): 87\u201395.","journal-title":"Haematologica"},{"issue":"21","key":"BFbjc201620_CR5","first-page":"2987","volume":"116","author":"D Hose","year":"2010","unstructured":"Hose D, Seckinger A, Goldschmidt H, Meissner T, Leber B, Neben K, Hillengass J, Bertsch U, Janssen B, Klein B, Lewis J, Vanderkerken K, Schultes C (2010) A novel class of sulfonanilides entering clinical trials for targeted treatment of multiple myeloma: dual-mechanism compounds inhibiting hif1a-signaling and inducing apoptosis. ASH Annual Meeting Abstracts 116 (21): 2987.","journal-title":"ASH Annual Meeting Abstracts"},{"issue":"6","key":"BFbjc201620_CR6","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1242\/dmm.008961","volume":"5","author":"J Hu","year":"2012","unstructured":"Hu J, Van Valckenborgh E, Menu E, De Bruyne E, Vanderkerken K (2012) Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models. Dis Model Mech 5 (6): 763\u2013771.","journal-title":"Dis Model Mech"},{"issue":"8","key":"BFbjc201620_CR7","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/1535-7163.MCT-09-0150","volume":"8","author":"Y Hu","year":"2009","unstructured":"Hu Y, Kirito K, Yoshida K, Mitsumori T, Nakajima K, Nozaki Y, Hamanaka S, Nagashima T, Kunitama M, Sakoe K, Komatsu N (2009) Inhibition of hypoxia-inducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan. Mol Cancer Ther 8 (8): 2329\u20132338.","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"BFbjc201620_CR8","doi-asserted-by":"publisher","first-page":"e42161","DOI":"10.1371\/journal.pone.0042161","volume":"7","author":"A Kassambara","year":"2012","unstructured":"Kassambara A, Hose D, Moreaux J, Reme T, Torrent J, Rossi JF, Goldschmidt H, Klein B (2012) Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myeloma. PLoS One 7 (7): e42161.","journal-title":"PLoS One"},{"issue":"1","key":"BFbjc201620_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ccr.2004.06.009","volume":"6","author":"AL Kung","year":"2004","unstructured":"Kung AL, Zabludoff SD, France DS, Freedman SJ, Tanner EA, Vieira A, Cornell-Kennon S, Lee J, Wang B, Wang J, Memmert K, Naegeli HU, Petersen F, Eck MJ, Bair KW, Wood AW, Livingston DM (2004) Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell 6 (1): 33\u201343.","journal-title":"Cancer Cell"},{"issue":"10","key":"BFbjc201620_CR10","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/leu.2011.122","volume":"25","author":"SK Martin","year":"2011","unstructured":"Martin SK, Diamond P, Gronthos S, Peet DJ, Zannettino AC (2011) The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma. Leukemia 25 (10): 1533\u20131542.","journal-title":"Leukemia"},{"issue":"4","key":"BFbjc201620_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3324\/haematol.2010.033456","volume":"96","author":"J Moreaux","year":"2011","unstructured":"Moreaux J, Klein B, Bataille R, Descamps G, Maiga S, Hose D, Goldschmidt H, Jauch A, Reme T, Jourdan M, Amiot M, Pellat-Deceunynck C (2011) A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines. Haematologica 96 (4): 574\u2013582.","journal-title":"Haematologica"},{"issue":"12","key":"BFbjc201620_CR12","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1158\/1535-7163.MCT-12-0721","volume":"11","author":"J Moreaux","year":"2012","unstructured":"Moreaux J, Reme T, Leonard W, Veye JL, Requirand G, Goldschmidt H, Hose D, Klein B (2012) Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitors. Mol Cancer Ther 11 (12): 2685\u20132692.","journal-title":"Mol Cancer Ther"},{"key":"BFbjc201620_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1476-4598-13-91","volume":"13","author":"KM Reece","year":"2014","unstructured":"Reece KM, Richardson ED, Cook KM, Campbell TJ, Pisle ST, Holly AJ, Venzon DJ, Liewehr DJ, Chau CH, Price DK, Figg WD (2014) Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1alpha\/p300 complex in a preclinical model of prostate cancer. Mol Cancer 13: 91.","journal-title":"Mol Cancer"},{"issue":"5","key":"BFbjc201620_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/onc.2009.441","volume":"29","author":"GL Semenza","year":"2010","unstructured":"Semenza GL (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29 (5): 625\u2013634.","journal-title":"Oncogene"},{"issue":"8","key":"BFbjc201620_CR15","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1038\/leu.2013.24","volume":"27","author":"P Storti","year":"2013","unstructured":"Storti P, Bolzoni M, Donofrio G, Airoldi I, Guasco D, Toscani D, Martella E, Lazzaretti M, Mancini C, Agnelli L, Patrene K, Maiga S, Franceschi V, Colla S, Anderson J, Neri A, Amiot M, Aversa F, David Roodman G, Giuliani N (2013) Hypoxia-inducible factor (HIF)-1alpha suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction. Leukemia 27 (8): 1697\u20131706.","journal-title":"Leukemia"},{"issue":"4","key":"BFbjc201620_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.stem.2011.02.006","volume":"8","author":"Y Wang","year":"2011","unstructured":"Wang Y, Liu Y, Malek SN, Zheng P, Liu Y (2011) Targeting HIF1alpha eliminates cancer stem cells in hematological malignancies. Cell Stem Cell 8 (4): 399\u2013411.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"BFbjc201620_CR17","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1158\/0008-5472.CAN-08-4603","volume":"69","author":"J Zhang","year":"2009","unstructured":"Zhang J, Sattler M, Tonon G, Grabher C, Lababidi S, Zimmerhackl A, Raab MS, Vallet S, Zhou Y, Cartron MA, Hideshima T, Tai YT, Chauhan D, Anderson KC, Podar K (2009) Targeting angiogenesis via a c-Myc\/hypoxia-inducible factor-1alpha-dependent pathway in multiple myeloma. Cancer Res 69 (12): 5082\u20135090.","journal-title":"Cancer Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc201620.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc201620","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc201620.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:33:04Z","timestamp":1684416784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc201620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,11]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFbjc201620"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2016.20","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,11]]},"assertion":[{"value":"31 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}